SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genentech (NYSE:DNA) formerly known as (NYSE:GNE)
An SI Board Since July 1999
Posts SubjectMarks Bans Symbol
250 46 0 DNA
Emcee:  esecurities(tm) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
225>>Special Committee of Genentech Board of Directors Responds to Roche'tuck-1/30/2009
224Hah! That moved the range of the 2011 Leaps down noticeably. Wonder if this platuck-1/30/2009
223LOL, actually, I've tried to read Sartor Resartus many times, but have nevertom pope-1/30/2009
222Here is a little piece from an interview he gave... Benjamin: How would you deskenhott-1/30/2009
221!!!!!!!!! Not what I for one expected. Does this fit Mr Humer? <i>'Atom pope-1/30/2009
220Roche goes hostile, cuts Genentech bid to $42 billion Fri Jan 30, 2009 11:50am Gkenhott-1/30/2009
219Probably the first time a biotech was happy to report adverse events.... Event rkrw-12/22/2008
218Hi folks, who knows Dr Arndt Schottelius? Is something interesting to tell aboutGermanecki-12/10/2008
217ALSO Avastin Analysis Finds Link to Blood-Clot Risk By THOMAS GRYTA A new antom pope-11/19/2008
216FDA Adds Warning To Genentech’s Raptiva <i>[Old news but I hadn't seentnsaf-11/19/2008
215Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in tnsaf-11/19/2008
214Roche Says Tarceva Data Promising A WALL STREET JOURNAL NEWS ROUNDUP NOVEMBER Doc Bones-11/10/2008
213Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects: siliconinDewDiligence_on_SI-11/3/2008
212Sales of Genentech’s Cancer Drug Climb By REUTERS Published: October 14, 2008 Doc Bones-10/15/2008
211Genentech Set Back by Cancer-Drug Study OCTOBER 7, 2008 Genentech Inc. and OSDoc Bones-10/7/2008
210Could Market Turmoil Foil Roche’s Bid for Genentech? Posted by Sarah RubensteinDoc Bones-9/30/2008
209What Now, Genentech Investors? Adam Feuerstein 07/23/08 - 06:59 AM EDT (EditoDoc Bones-7/24/2008
208Roche offers to buy Genentech.. news.yahoo.com BASEL, Switzerland (Reuters) - zeta1961-7/21/2008
207Genentech Net Up 4.7% By THOMAS GRYTA July 15, 2008; Page B9 Genentech Inc.Doc Bones-7/15/2008
206Genentech ends studies on drug combo safety issue Monday July 14, 6:35 pm ET Gentnsaf-7/15/2008
205Costly Cancer Drug Offers Hope, but Also a Dilemma [NYT] By GINA KOLATA and ANDDoc Bones-7/5/2008
204Genentech to Focus Research On Neuroscience, Infectious Disease By KATHY SHWIFDoc Bones-6/12/2008
203>>Genentech Settles Dispute Related to Cabilly Patent Wednesday June 11, 4tuck-6/11/2008
202Doesn't seem to be having much effect yet, tho IMCL is getting a boost on detom pope-4/21/2008
201Merrill again. It's become cheap enough to buy, I think. Initial Avastin C-tom pope-4/18/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News